Literature DB >> 15139506

Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a metanalysis.

Suku George1, Arvind A Kulkarni, Gary Stevens, Chris E Forsmark, Peter Draganov.   

Abstract

The role of osmolality of contrast media (CM) in the development of post-ERCP pancreatitis (PEP) is debated. We therefore performed a metanalysis to determine whether osmolality affects the incidence of PEP. A literature search of English-language studies was performed using computerized databases and manual searching of abstracts and article bibliographies. Randomized controlled trials comparing the incidence of PEP associated with high- and low-osmolality contrast media (HOCM, LOCM) were considered. The outcome assessed was clinical pancreatitis as evidenced by both elevation of pancreatic enzymes and pain. Data were analyzed using logistic regression with terms for study and osmolality. Fisher's exact test was done to compare PEP rates. Homogeneity between studies was indicated by the nonsignificance of the study effect in the logistic regression model. Logistic regression also indicated no difference in PEP rates between LOCM and HOCM (P = 0.399). Comparison of PEP rates in both groups using Fisher's exact test did not indicate a difference in any individual study (all P values > 0.05). Due to the large variation of study sample sizes, we repeated the analysis by creating three study groups. The effect of osmolality was invariant to how the data were combined. The results of this metanalysis indicate that there is no significant difference between HOCM and LOCM with respect to clinical PEP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139506     DOI: 10.1023/b:ddas.0000020511.98230.20

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.

Authors:  T P Short; E Thomas
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

2.  Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).

Authors:  A Kruse; A Brock; J Rodenberg; E Nowakowska-Duawa; K Bjartveit
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

3.  The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.

Authors:  P Mäkelä; P B Dean
Journal:  Eur J Radiol       Date:  1986-11       Impact factor: 3.528

4.  Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.

Authors:  A K Banerjee; S L Grainger; R P Thompson
Journal:  Br J Clin Pract       Date:  1990-11

5.  Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group.

Authors:  G K Johnson; J E Geenen; J F Johanson; S Sherman; W J Hogan; O Cass
Journal:  Gastrointest Endosc       Date:  1997-09       Impact factor: 9.427

6.  Outcomes of endoscopy procedures: struggling towards definitions.

Authors:  P B Cotton
Journal:  Gastrointest Endosc       Date:  1994 Jul-Aug       Impact factor: 9.427

7.  Morphology of the pancreatic ductal epithelium after traumatization of the papilla of Vater or endoscopic retrograde pancreatography with various contrast media in cats.

Authors:  H Bub; W Bürner; J F Riemann; M Stolte
Journal:  Scand J Gastroenterol       Date:  1983-07       Impact factor: 2.423

8.  A comparative study of contrast agents for endoscopic retrograde pancreatography.

Authors:  J S Barkin; G L Casal; D K Reiner; R I Goldberg; R S Phillips; S Kaplan
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

9.  A randomised, prospective study comparing two contrast media in ERCP.

Authors:  W J Cunliffe; I Cobden; M I Lavelle; R Lendrum; N P Tait; C W Venables
Journal:  Endoscopy       Date:  1987-09       Impact factor: 10.093

10.  Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.

Authors:  S Sherman; R H Hawes; S W Rathgaber; M F Uzer; M T Smith; Q E Khusro; W B Silverman; D T Earle; G A Lehman
Journal:  Gastrointest Endosc       Date:  1994 Jul-Aug       Impact factor: 9.427

View more
  17 in total

1.  Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.

Authors:  Nicholas M Szary; Firas H Al-Kawas
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

2.  Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.

Authors:  Kevin E Woods; Field F Willingham
Journal:  World J Gastrointest Endosc       Date:  2010-05-16

3.  Is post-endoscopic retrograde cholangiopancreatography pancreatitis the same as acute clinical pancreatitis?

Authors:  Tetsuya Mine
Journal:  J Gastroenterol       Date:  2007-03       Impact factor: 7.527

4.  Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.

Authors:  Shunqian Jin; Abrahim I Orabi; Tianming Le; Tanveer A Javed; Swati Sah; John F Eisses; Rita Bottino; Jeffery D Molkentin; Sohail Z Husain
Journal:  Gastroenterology       Date:  2015-05-14       Impact factor: 22.682

Review 5.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

6.  Effects of contrast media on the hepato-pancreato-biliary system.

Authors:  Omer Topcu; Atilla Kurt; Isilay Nadir; Sema Arici; Ayhan Koyuncu; Cengiz Aydin
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

Review 7.  Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.

Authors:  John G Lieb; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

Review 8.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis.

Authors:  Hiroki Yuhara; Masami Ogawa; Yoshiaki Kawaguchi; Muneki Igarashi; Tooru Shimosegawa; Tetsuya Mine
Journal:  J Gastroenterol       Date:  2013-05-30       Impact factor: 7.527

9.  Prevention of Post-ERCP Pancreatitis.

Authors:  F Donnellan; Michael F Byrne
Journal:  Gastroenterol Res Pract       Date:  2011-08-10       Impact factor: 2.260

Review 10.  Pancreatitis after endoscopic retrograde cholangiopancreatography: A narrative review.

Authors:  Igor Braga Ribeiro; Epifanio Silvino do Monte Junior; Antonio Afonso Miranda Neto; Igor Mendonça Proença; Diogo Turiani Hourneaux de Moura; Mauricio Kazuyoshi Minata; Edson Ide; Marcos Eduardo Lera Dos Santos; Gustavo de Oliveira Luz; Sergio Eiji Matuguma; Spencer Cheng; Renato Baracat; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.